James Cheng Chung News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A propensity score matched analysis suggests use of SGLT2 inhibitors could reduce risk of negative outcomes in patients with systemic lupus erythematosus and type 2 diabetes.

James cheng chungLinkedin james cheng chungChung shan medical university hospitalHazard ratioConfidence intervalNephritis among patients with systemic lupusRedefining cardiometabolic